- Home
- IRON vs STR Comparison
IRON vs STR Comparison
Compare IRON & STR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- STR
- Stock Information
- Founded
- IRON 2017
- STR 2016
- Country
- IRON United States
- STR United States
- Employees
- IRON N/A
- STR N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- STR Oil & Gas Production
- Sector
- IRON Health Care
- STR Energy
- Exchange
- IRON Nasdaq
- STR Nasdaq
- Market Cap
- IRON 1.4B
- STR 1.2B
- IPO Year
- IRON N/A
- STR N/A
- Fundamental
- Price
- IRON $44.24
- STR $17.86
- Analyst Decision
- IRON Strong Buy
- STR Buy
- Analyst Count
- IRON 10
- STR 6
- Target Price
- IRON $83.80
- STR $25.80
- AVG Volume (30 Days)
- IRON 397.9K
- STR 790.9K
- Earning Date
- IRON 05-07-2025
- STR 05-07-2025
- Dividend Yield
- IRON N/A
- STR 7.86%
- EPS Growth
- IRON N/A
- STR N/A
- EPS
- IRON N/A
- STR 0.52
- Revenue
- IRON N/A
- STR $636,538,000.00
- Revenue This Year
- IRON N/A
- STR N/A
- Revenue Next Year
- IRON N/A
- STR $2.54
- P/E Ratio
- IRON N/A
- STR $34.21
- Revenue Growth
- IRON N/A
- STR 7.18
- 52 Week Low
- IRON $28.25
- STR $14.58
- 52 Week High
- IRON $68.73
- STR $25.64
- Technical
- Relative Strength Index (RSI)
- IRON 45.99
- STR 53.77
- Support Level
- IRON $40.36
- STR $16.75
- Resistance Level
- IRON $47.21
- STR $18.51
- Average True Range (ATR)
- IRON 2.87
- STR 0.51
- MACD
- IRON 0.10
- STR 0.20
- Stochastic Oscillator
- IRON 37.67
- STR 66.67
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About STR Sitio Royalties Corp.
Sitio Royalties Corp is a pure-play mineral and royalty company. The group focuses on investing in mineral and royalty interests in the Permian and other productive U.S. oil basins.